Skip to main content

Vedolizumab (Entyvio®) Therapy

Last Update
Extension
.pdf
Print Code
QV85-1623
Language
English
Creator
Nova Scotia Collaborative IBD Program

Vedolizumab (Entyvio®) is given to manage inflammatory bowel disease (IBD), ulcerative colitis, or Crohn's disease. This pamphlet gives you information about vedolizumab to help you make an informed decision about whether or not to use it. 

©2024 Nova Scotia Health Authority. All rights reserved.